Evolent Health (EVH) PT Lowered to $3.50 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Sean Dodge lowered the price target on Evolent Health (NYSE: EVH) to $3.50 (from $7.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
